FibroGen Inc (FGEN)

Currency in USD
7.230
-0.320(-4.24%)
Closed·
After Hours
7.2300.000(0.00%)
·

FGEN Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.05 / -0.10
Revenue / Forecast
2.74M / 35.50M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-0.09--/2.88M----Free Sign Up
03/20250.05/-0.12.74M/35.5M+150%-92.28%Free Sign Up
12/20240.18/-0.173.1M/22.09M+205.88%-85.97%Free Sign Up
09/2024-0.17/-0.3146.3M/34.84M+45.16%+32.89%Free Sign Up
06/2024-0.16/-0.3250.6M/34.66M+50%+45.99%Free Sign Up
03/2024-0.33/-0.4155.9M/36.45M+19.51%+53.36%Free Sign Up
12/2023-0.57/-0.4427.1M/38.78M-29.55%-30.12%Free Sign Up
09/2023-0.65/-0.6840.1M/36.84M+4.41%+8.85%Free Sign Up
06/2023-0.9/-0.744.32M/34.73M-28.57%+27.61%Free Sign Up
03/2023-0.81/-0.7536.16M/31.67M-8%+14.18%Free Sign Up

All numbers in USD

FibroGen Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue fell to $2.7M from $25.4M YoY; net loss reduced to $16.8M. Stock rose 2.13% to $0.312 in aftermarket trading.
  • FibroGen China divestment to AstraZeneca expected to close Q3 2025, strengthening finances and extending cash runway to H2 2027.
  • Phase II trial for FG3246 in prostate cancer set for Q3 2025. Seeking FDA feedback on Roxadustat for anemia treatment.
  • 2025 revenue guidance: $4M-$8M. Operating costs down 76% YoY. R&D expenses reduced 75% YoY to $9.2M.
  • Cash position: $128.4M total, $33.8M in US. Divestment proceeds to reduce debt and support operations.
Last Updated: 12/05/2025, 22:50
Read Full Transcript

FAQ

What Is FibroGen Inc's Earnings Per Share (TTM)?

The FibroGen Inc EPS (TTM) is -30.04.

When Is The Next FibroGen Inc Earnings Date?

FibroGen Inc will release its next earnings report on 10 Aug 2025.

What Is FibroGen Inc’s Revenue Forecasts For Upcoming Quarters?

FibroGen Inc’s revenue forecast is 2.88M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.